NRC

NRC

USD

National Research Corporation Common Stock (Delaware)

$14.700+0.360 (2.510%)

Reaalajas hind

Healthcare
Health Information Services
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$14.340

Kõrge

$14.775

Madal

$14.135

Maht

0.01M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

333.1M

Tööstusharu

Health Information Services

Riik

United States

Kauplemisstatistika

Keskmine maht

0.10M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $9.755Praegune $14.700Kõrge $21.64

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 3. nov 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

NRC Stock Update: National Research Corp Shows Volatile Recovery Pattern

Price Movement Summary

  • Recent Close: $13.43 (Nov 3) after bouncing from $11.28 low (Oct 10)
  • 3-Month Range: $11.28 - $16.14 (-30% peak-to-trough)
  • Key Catalyst: October 28 surge (+16% on 273k volume - 2.7x average)

Breaking Down the Action

  1. August Strength Steady climb from $12.58 to $16.03 (27% gain) on average volume, peaking Sept 9.

  2. September Breakdown Sharp 31% collapse from $16.03 to $11.48 over six weeks, accelerated by high-volume selling Sept 19 (-6.9%) and Sept 29 (-6.2%).

  3. October Rebound October 28 explosion ($11.43→$13.25) marked strongest single-day gain since August. Subsequent consolidation between $12.62-$13.45 suggests new trading range forming.

Technical Positioning

  • Bullish Signals: MACD crossover + volume surge confirm momentum shift
  • Immediate Resistance: $13.45-13.62 area (recent highs & Bollinger upper band)
  • Critical Support: $12.02-12.62 zone (October rebound base)
  • Volume Profile: Sustained above-average trading since rebound (115k-141k vs 101k avg)

Fundamental Context

MetricValueImplication
ROE66.9%Exceptional capital efficiency
⚠️Debt/Equity559%Highly leveraged structure
🔻Revenue Growth-3.4%Contracting operations
📊P/E11.57Below healthcare sector average

Strategic Considerations

For Active Traders

  • Near-term upside to $13.62 (+1.4%) if momentum holds
  • Stop-loss prudent below $12.75 (recent consolidation low)
  • Watch for volume confirmation on breakout attempts

Longer-Term Investors

  • High debt load raises sustainability questions
  • Negative growth contrasts with strong ROE - warrants deeper due diligence
  • Sector outlook for health analytics remains favorable despite company-specific risks

Recommended Action Plan

  1. Day Traders: Scalp $13.15-13.45 range with tight stops
  2. Swing Traders: Consider long positions above $13.30 targeting $13.62 exit
  3. Risk-Averse Investors: Monitor debt management progress before entry

Data reflects market conditions as of November 3, 2025 closing. Past performance ≠ future results. Consult a financial advisor before trading. Volatility risk elevated with 52-week range of $9.76-$21.64.

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Neutraalne

Uuendatud kell: 10. nov 2025, 13:54

LangevNeutraalneTõusev

65.2% Kindlus

Risk ja kauplemine

Riskitase4/5
Kõrge risk
Sobib
Mõõdukas
Kauplemisjuhend

Sisenemispunkt

$14.43

Võta kasum

$15.02

Peata kahjum

$13.26

Põhitegurid

PDI 19.4 on MDI 8.9 kohal ADX-iga 19.1, mis viitab tõusutrendile
Praegune hind on tugitaseme ($14.49) lähedal, mis viitab potentsiaalsele ostuvõimalusele
Kauplemismaht on 2.3x keskmisest (1,578), mis näitab märkimisväärset ostuhuvi
MACD 0.0541 on signaalijoone 0.0328 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.